Arthroplasty Physicians Trade Views If Not Blows At World Congress
Executive Summary
It was more knees than hips, on balance, but the inaugural World Arthroplasty Congress in mid-April brought surgeons from all parts of the world to Paris for three days of discussions, presentations, and discoveries. It was clear at the well-attended event that orthopedic physicians don’t all see eye-to-eye in a sector undergoing rapid change.
You may also be interested in...
Orthopedics Corner: Catalyst Looks To Clinical Data To Distinguish Its Shoulder Arthroplasty Technology
Orthopedics Corner is a new series highlighting new developments in spine and orthopedics technology you may have missed. Catalyst OrthoScience CEO Carl O’Connell, along with surgeon and researcher Matthew Budge, talked to Medtech Insight about Catalyst’s innovation in shoulder arthroplasty.
Zimmer Biomet Adds CD Diagnostics To List Of 2016 Acquisitions
The deal will add musculoskeletal diagnostic tests to Zimmer Biomet's new Signature Solutions consulting and technology program. It is the orthopedics giant's sixth acquisition of 2016.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.